A major British trial of hydroxychloroquine has found it has “no benefit” for patients hospitalized with COVID-19, researchers said Friday, announcing they had halted tests of the drug.
“We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalized with COVID-19,” said a statement from the chief investigators in the randomized clinical trial, which is run by the University of Oxford and is testing a number of potential treatments for the new coronavirus.
They added they would stop recruiting patients to the hydroxychloroquine part of the trial “with immediate effect.”
